Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review
Vivek P. Chavda, Jinal Ajabiya, Divya Teli, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4315-4315
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Beyond 20 in the 21st Century: Prospects and Challenges of Non-canonical Amino Acids in Peptide Drug Discovery
Jennifer L. Hickey, Dan Sindhikara, Susan L. Zultanski, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 557-565
Open Access | Times Cited: 70
Glucagon‐like peptide agonists: A prospective review
Zamara Mariam, Sarfaraz K. Niazi
Endocrinology Diabetes & Metabolism (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 45
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreaticβ-Cell Function and Diabetes
Matthew J. Varney, Jeffrey Benovic
Pharmacological Reviews (2024) Vol. 76, Iss. 2, pp. 267-299
Open Access | Times Cited: 16
Peptide-Drug Conjugates: A New Hope for Cancer Management
Vivek P. Chavda, Hetvi K. Solanki, Majid Davidson, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7232-7232
Open Access | Times Cited: 53
Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
Baptist Gallwitz
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 41
Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
Yasmin Mesquita, Izabela Pera Calvi, Isabela Reis Marques, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 10, pp. 883-892
Closed Access | Times Cited: 27
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
Inês Domingues, Isabelle Leclercq, Ana Beloqui
Journal of Controlled Release (2023) Vol. 363, pp. 415-434
Closed Access | Times Cited: 27
Tirzepatida: Un Avance Revolucionario en el Tratamiento de la Diabetes Mellitus Tipo 2 y la Obesidad
Mariana Chávez
Revista Veritas de Difusão Cientifica. (2023) Vol. 4, Iss. 1, pp. 96-110
Open Access | Times Cited: 25
Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges
Kanghong Hu, Huizhong Huang, Hanluo Li, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 24
Effect of tirzepatide on blood pressure and lipids: A meta‐analysis of randomized controlled trials
Mehmet Kanbay, Sidar Çöpür, Dimitrie Siriopol, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 12, pp. 3766-3778
Closed Access | Times Cited: 21
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials
Gustavo de Oliveira Almeida, Thiago Nienkötter, Caroline Cristine Almeida Balieiro, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 4, pp. 509-521
Closed Access | Times Cited: 8
Predictors of weight reduction effectiveness of SGLT2 inhibitors in diabetes mellitus type 2 patients
Pojsakorn Danpanichkul, Worapaka Manosroi, Tharadon Nilsirisuk, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 7
Glucagon-Like Peptide-1 Agonists and General Anesthesia: Perioperative Considerations and the Utility of Gastric Ultrasound
Conner M Willson, L. Patel, Peter G. Middleton, et al.
Cureus (2024)
Open Access | Times Cited: 7
360-Degree Perspectives on Obesity
Magdalena Cuciureanu, Cătălin-Cezar Caratașu, Levon Gabrielian, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1119-1119
Open Access | Times Cited: 20
GLP-1R Signaling and Functional Molecules in Incretin Therapy
Wenwei Wan, Qikai Qin, Linshan Xie, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 751-751
Open Access | Times Cited: 19
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
Valeria Guglielmi, Silvia Bettini, Paolo Sbraccia, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 2, pp. 127-146
Open Access | Times Cited: 17
Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management
Magda Wojtara, A Mazumder, Yusra Syeda, et al.
Advances in Medicine (2023) Vol. 2023, pp. 1-7
Open Access | Times Cited: 17
Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
Isabella Zaffina, Maria Chiara Pelle, Giuseppe Armentaro, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis
Qingyue Zeng, Jiao Xu, Xingyu Mu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Pharmacotherapy before and after bariatric surgery
Khaled Alabduljabbar, Carel W. le Roux
Metabolism (2023) Vol. 148, pp. 155692-155692
Closed Access | Times Cited: 15
Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment
Ewa Radzioch, Bartłomiej Dąbek, Marta Balcerczyk-Lis, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 765-765
Open Access | Times Cited: 6
Unlocking longevity with GLP-1: A key to turn back the clock?
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Maturitas (2024) Vol. 186, pp. 108028-108028
Closed Access | Times Cited: 6
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review
Janet B. McGill, Irl B. Hirsch, Christopher G. Parkin, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1085-1098
Open Access | Times Cited: 5
Tirzepatide-related acute liver injury
Irrum Abdullah, Husam El-Ghousain, Meshaan Alenezi
European Journal of Case Reports in Internal Medicine (2024)
Open Access | Times Cited: 5
Aqueous Extract of Cornus officinalis Alleviate NAFLD via Protecting Hepatocytes Proliferation through Regulation of the Tricarboxylic Acid Cycle
Binjie Liu, Ting Shao, Dandan Xiao, et al.
Journal of Ethnopharmacology (2025) Vol. 341, pp. 119330-119330
Closed Access
Page 1 - Next Page

Scroll to top